Authors
Latest:
Q&A: Statin, Nonstatin Combination Therapy to Treat Patients’ Cardiovascular Risk | ASHP MidyearJohn Bucheit, PharmD, joined Drug Topics to discuss statins and nonstatins’ efficacy in treating cardiovascular disease.
Latest:
Drug Review: Lebrikizumab-lbkz Demonstrates Improvement in Atopic DermatitisFDA approval was granted on September 13, 2024.
Latest:
Understanding the Foundations of Pharmacy Financial HealthPharmacy schools specialize in training students as experts in patient care—not as expert business owners.
Latest:
Mind-Body Resilience for Women: A Focus on DepressionDeveloping innovative solutions for women with depression, accounting for differences in gender and sex, are critically important
Latest:
FDA: Secukinumab Approved for Hidradenitis SuppurativaSecukinumab is the only anti IL-17A inhibitor approved for hidradenitis suppurativa.
Latest:
USDA provides conditional license for Canine Parvovirus Monoclonal AntibodyThe brand-new treatment from Elanco is currently the only approved therapeutic solution proven to treat canine parvovirus.
Latest:
Q&A: Ultra-High-Cost Drugs Highlight Complex US Health Care SystemErin Fox, PharmD, MHA, BCPS, FASHP, discussed the 2025 Pharmacy Forecast and its perspective on managing ultra-high-cost drugs.
Latest:
What's Next in Development of RSV Vaccines for Children?How much progress have we made in developing therapies to treat this common childhood respiratory disorder?
Latest:
FDA Approves Drug Combo for Young Glioma PatientsA combination of dabrafenib with trametinib was approved by the FDA for treatment of pediatric patients 1 year and older with low-grade glioma & BRAF V600E mutation who require systemic therapy.
Latest:
Probiotics for the Prevention of Pediatric Antibiotic-Associated DiarrheaEvidence of the relationship between probiotics and antibiotics is lacking.
Latest:
Probiotics for the Prevention of Pediatric Antibiotic-Associated DiarrheaEvidence of the relationship between probiotics and antibiotics is lacking.
Latest:
How Pharmacy Matches Perfectly With NutritionKnown as “The Nutrition Pharmacist,” Sarah Gray, PharmD, GAICD, recently joined Drug Topics to discuss her dual profession within health care.
Latest:
Mind-Body Resilience for Women: A Focus on DepressionDeveloping innovative solutions for women with depression, accounting for differences in gender and sex, are critically important
Latest:
The Wait for RSV Vaccines ContinuesTwo RSV vaccines for seniors have completed phase 3 trials and demonstrated beneficial results. The public still awaits FDA decisions on potential approvals for both.
Latest:
Vericiguat (Verquvo) for Heart Failure With Reduced Ejection FractionA new drug review for vericiguat, indicated for heart failure, reports efficacy and safety data.
Latest:
Two Lawsuits Allege Iowa Medicaid Did Not Provide Proper Mental Health CareIowa's Department of Health and Human Services, which manages the two health insurers that delivered care to adults and children in the state’s Medicaid program last year, was alleged to provide inadequate mental and behavioral health care to children on Medicaid.
Latest:
Probiotics for the Prevention of Pediatric Antibiotic-Associated DiarrheaEvidence of the relationship between probiotics and antibiotics is lacking.
Latest:
Assessing and Treating Opioid Use Disorder in PregnancyOpioid use disorder during pregnancy is stigmatized, but these patients deserve compassionate, nonjudgmental care.
Latest:
Misdosing: More Common Than You ThinkUnfortunately, even though the need for making proper dose adjustments for kidney function is well-recognized, clinicians face many challenges in doing so.
Latest:
FDA Approves Ensifentrine, Novel Treatment for Chronic Obstructive Pulmonary DiseaseOn June 26, 2024, the FDA approved ensifentrine (Ohtuvayre) for the treatment of COPD.
Latest:
COVID-19 Omicron Variant Associated with Lower Risk of Severe Illness vs Delta VariantVaccination greatly reduces the probability of experiencing severe COVID-19 in both variants. Adults between the ages of 40 to 59 years saw the most significant reduction in risk when compared to individuals in other age categories.
Latest:
Assessing Medicaid Policy Barriers to Gene, Cell TherapiesResearchers of a new paper discuss the inconsistencies between gene and cell therapy indications and payor coverage.
Latest:
The Chronic Complications For Children With T1DMPart of the risk of developing kidney involvement begins when type 1 diabetes mellitus (T1DM) sets in and establishes itself in the patient, with up to 65% of children experiencing acute kidney injury during T1DM onset, which can further predispose to the development of future chronic kidney disease.
Latest:
Combining Keytruda And Chemo May Improve Survival in Advanced Endometrial CancerPatients with advanced or recurrent endometrial cancer treated with Keytruda plus chemotherapy had improved progression-free survival compared with chemotherapy alone.
Latest:
Ethical, Practical Considerations of Exemptions to Employer Vaccine Mandates for AnxietyDoes anxiety justify an exemption from vaccine mandates among health care workers?
Latest:
Fertility Treatments Equally Effective in Women With, Without PCOSWomen with PCOS were more likely to begin fertility treatment with ovulation induction compared to those without PCOS.
Latest:
Challenges Facing Healthcare: The Unvaccinated COVID-19 PatientDo no harm, even though your patient might.
Latest:
New Drug Approvals in PediatricsThis past year has seen several important new drug approvals and labeling updates for children. Here is what you should know.
Latest:
Advanced Hybrid Closed-Loop Technology Could Improve Quality of Life in Type 1 DiabetesA 1-year observational follow-up of a 3-month randomized controlled trial provides insight into the benefits of advanced hybrid closed-loop system use in people with type 1 diabetes using multiple daily injections and self-monitoring of blood glucose.
